A medication used to treat adults addicted to or dependent on opiates such as pain medications, heroin or methadone. It is available in oral form (sublingual tablets) and injectable form. As part of an addiction treatment program, the medication is taken in its oral form. Buprenorphine blocks the effects of other opiates and eliminates cravings and symptoms of withdrawal.
A medication used in opioid substitution therapy programs. It is included in the World Health Organization (WHO) Model List of Essential Medicines.
Currently, this drug is in the experimental stages for treatment of heroin dependence.
A drug used to treat opiate addiction; it is a partial agonist of the m receptors and an antagonist of the K receptors, to which it is very similar. It produces a weaker opiate effect than pure agonists, such as morphine and methadone. It is effective both in detoxification and maintenance programs. The drug has scarce abuse potential, produces little physical dependence, presents negligible risks of overdose, and is easy to use. The most important experience based on the use of this medication was carried out in France.
A new medication awaiting FDA approval for treatment of opioid addiction. It blocks the effects of opioids on the brain.
(Also known as Temgesic and Subutex.) New substances that have proven to reduce cravings associated with heroin withdrawal. May also be helpful in treating cocaine addiction.
A partial opiate agonist, buprenorphine can either activate or block opoid receptors. Used in conjunction with Naloxone it becomes Suboxone ® and in conjunction with naltrexone it becomes Subutex ®. Buprenorphine is a powerful and relatively new tool in the fight against opiate addiction.
Morphine synthetic by-product, in France is used in substitution treatment for opiates Heroin: Diacetylmorphine, white paste or dust synthesized from morphine. Rail: Cocaine line.
A long-lasting opiate analgesic that has both opiate agonist and antagonist properties. Buprenorphine may be useful for treating heroin addiction.
A mixed opiate agonist/antagonist medication for the treatment of heroin addiction.
A long-lasting opiate analgesic that has both opiate agonist and antagonist properties. Buprenorphine shows promise for treating heroin addiction.
Buprenorphine, also colloquially referred to as bupe or subbies, is an opioid drug with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as Buprenex in a 0.3 mg/ml injectable formulation in the United States, yet is now primarily used for the treatment of opioid addiction, since FDA approval of Suboxone and Subutex, buprenorphine's high-dose preparations approved for opioid addiction, in late 2001. It has been a Schedule III drug under the Convention on Psychotropic Substanceshttp://www.incb.org/pdf/e/list/green.pdf List of psychotropic Substances under international control since it was rescheduled from Schedule V (the schedule with the lowest restrictions and penalties) just before FDA approval of Suboxone and Subutex.